Cellebrite DI Ltd.
CLBT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $3,845,737 | $4,829,812 | $5,138,453 |
| - Cash | $281,361 | $179,223 | $90,475 | $191,659 |
| + Debt | $17,821 | $22,331 | $10,603 | $10,969 |
| Enterprise Value | – | $3,688,845 | $4,749,940 | $4,957,763 |
| Revenue | $126,029 | $113,276 | $107,549 | $109,049 |
| % Growth | 11.3% | 5.3% | -1.4% | – |
| Gross Profit | $105,715 | $95,599 | $90,059 | $91,425 |
| % Margin | 83.9% | 84.4% | 83.7% | 83.8% |
| EBITDA | $26,991 | $17,009 | $14,899 | $18,456 |
| % Margin | 21.4% | 15% | 13.9% | 16.9% |
| Net Income | $20,189 | $19,476 | $17,400 | $19,269 |
| % Margin | 16% | 17.2% | 16.2% | 17.7% |
| EPS Diluted | 0.08 | 0.078 | 0.07 | 0.078 |
| % Growth | 2.3% | 11.7% | -10.1% | – |
| Operating Cash Flow | $33,272 | $32,583 | $20,878 | $65,967 |
| Capital Expenditures | -$3,322 | -$3,608 | -$2,339 | -$4,317 |
| Free Cash Flow | $29,950 | $28,975 | $18,539 | $61,650 |